Companies / Santa Cruz Biotechnology / Cdc20 (H-7) AC
Santa Cruz Biotechnology

Cdc20 (H-7) AC | Santa Cruz Biotechnology

mouse monoclonal IgG2b; Cdc20 Antibody (H-7) is an IgG2b κ mouse monoclonal Cdc20 antibody that detects Cdc20 of mouse, rat and human origin by WB, IP, IF, IHC(P) and ELISA. Cdc20 Antibody (H-7) is available as the non-conjugated anti-Cdc20 antibody form, as well as multiple conjugated forms of anti-Cdc20 antibody, including agarose, HRP, PE, FITC and multiple Alexa Fluor® conjugates. Cyclins, regulatory subunits which associate with kinases, control many of the important steps in cell cycle progression. The Cdc2 protein kinase (p34Cdc2) exhibits protein kinase activity in vitro and exists in a complex with both cyclin B and a protein homologous to p13suc 1. Cdc2 kinase is the active subunit of the M phase promoting factor (MPF) and the M phase-specific histone H1 kinase. The p34Cdc2/cyclin B complex is required for the G2 to M transition. An additional cell cycle-dependent protein kinase termed p55 CDC exhibits a high degree of homology with the S. cerevisiae proteins Cdc20 and Cdc4. The Cdc20 transcript is readily detectable in a variety of cultured cell lines in growth phase, but disappears when cell growth is chemically arrested. Cdc20 shows kinase activity towards a-casein and myelin basic protein.

Reviews


No reviews yet

ABOUT THE COMPANY

Santa Cruz Biotechnology is a world leader in the development of products for the biomedical research market. Over the past 30+ years, the Company has focused on the ongoing development of research antibodies, siRNA and CRISPR Gene editing tools, biochemicals, labware and more recently has expanded into animal health care products. Santa Cruz Biotechnology has the highest commitment to quality and customer service.